dc.contributor.advisorDennis Verano, Rodolfo José 
dc.contributor.advisorBolaños Losada, Felipe 
dc.creatorCajamarca B., Jairo Hernán 
dc.creatorAlmonacid A., Juan Pablo 
dc.date.accessioned2018-07-11T15:26:22Z
dc.date.available2018-07-11T15:26:22Z
dc.date.created2018-06-21
dc.identifier.urihttp://repository.urosario.edu.co/handle/10336/18151
dc.descriptionEs limitada la evidencia sobre los factores que predicen la necesidad de oxigeno domiciliario, entre estos las complicaciones hospitalarias infecciosas y no infecciosas. Objetivo: Evaluar el papel de las complicaciónes hospitalarias como factores asociados al requerimiento de oxígeno domiciliario al egreso hospitalario y estimar la frecuencia de complicaciones infecciosas y complicaciones no infecciosas. Diseño: Cohorte prospectiva concurrente Metodología: Se baso en la población del estudio “Prescripción de oxígeno domiciliario al momento del egreso hospitalario y desarrollo de un modelo que predice su requerimiento”, compuesta por pacientes que ingresaron al servicio de urgencias de la Fundación Cardioinfantil entre marzo de 2017 y septiembre de 2017. Se incluyeron pacientes mayores de 18 años y aquellos con estancia hospitalaria superior o igual a 48 horas. Resultados: Se incluyeron 1227 pacientes encontrándose un 18% de prescripción de oxígeno domiciliario. La frecuencia de las complicaciones no infecciosas fue de 1,54% (IC95% 0,8% al 2,2%), y de las complicaciones infecciosas fue de 5,3% % (IC 4,6 al 7,5%). En el modelo de asociación ajustado a variables confusoras, las complicaciones hospitalarias mostraron ser un factor que se asocia a 4 veces más (p<0,001 IC 95% 2,4-6,73) a la necesidad de oxigeno domiciliario al egreso de la hospitalización. Conclusión: Existe asociación entre la necesidad de oxigeno domiciliario y las complicaciones hospitalarias.
dc.description.abstractThere is limited evidence on the factors that predict the need for home oxygen, among these infectious and non-infectious hospital complications. Objective: To evaluate the role of hospital complications as factors associated with the requirement of home oxygen at hospital discharge and to estimate the frequency of infectious complications and noninfectious complications. Design: Concurrent prospective cohort Methodology: It was based on the population of the study "Prescription of home oxygen at the time of hospital discharge and development of a model that predicts its requirement", composed of patients admitted to the emergency service of the Fundación Cardioinfantil between March 2017 and September 2017. Patients older than 18 years and those with hospital stay greater than or equal to 48 hours were included. Results: A total of 1227 patients were included, finding an 18% prescription of home oxygen. The frequency of non-infectious complications was 1.54% (95% CI 0.8% to 2.2%), and infectious complications were 5.3%% (CI 4.6 to 7.5%). In the association model adjusted for confounding variables, hospital complications were found to be a factor that is associated with 4 times more (p <0.001 IC 95% 2.4-6.73) to the need for home oxygen at discharge from hospitalization. Conclusion: There is an association between the need for home oxygen and hospital complications.
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectOxigeno domiciliario
dc.subjectComplicaciones infecciosas
dc.subjectComplicaciones no infecciosas
dc.subject.ddc615
dc.subject.lembOxigenoterapia
dc.subject.lembInfecciones
dc.titleFrecuencia de complicaciones hospitalarias y su papel como determinantes en la necesidad de oxígeno domiciliario
dc.typebachelorThesis
dc.publisherUniversidad del Rosario
dc.creator.degreeEspecialista en Medicina Interna
dc.publisher.programEspecialización en Medicina Interna
dc.publisher.departmentFacultad de Medicina
dc.subject.keywordHome oxygen
dc.subject.keywordInfectious complications
dc.subject.keywordNon-infectious complications
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.type.spaTrabajo de grado
dc.rights.accesoAbierto (Texto Completo)
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.source.bibliographicCitationHunt JM, Copland J, McDonald CF, Barter CE, Rochford PD, Pierce RJ. Cardiopulmonary response to oxygen therapy in hypoxaemic chronic airflow obstruction. Thorax. 1989 Nov;44(11):930–6
dc.source.bibliographicCitationBetancourt-Peña J, Tonguino-Rosero S. Impacto de la oxigenoterapia domiciliaria en la capacidad funcional de pacientes con enfermedad pulmonar obstructiva crónica. Rehabilitacion 2016;50:13-8
dc.source.bibliographicCitationStuart C, Bishop M, Clrak TJ, Cotes JE, Flenley DC, Howard P, Oldham D. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet Lond Engl. 1981 Mar 28;1(8222):681–6
dc.source.bibliographicCitationStein DA, Bradley BL, Miller WC. Mechanisms of Oxygen Effects on Exercise in Patients with Chronic Obstructive Pulmonary Disease. Chest. 1982 Jan 1;81(1):6–10
dc.source.bibliographicCitationKvale P, Conway W, Bower C, Zych C, Mcburney A, Baird D. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med. 1980 Sep;93(3):391–8
dc.source.bibliographicCitationSivakumaran P, Garrett JE. The prescription of domicilary long-term oxygen therapy in Auckland. N Z Med J. 1996 Nov 22;109(1034):439–42.
dc.source.bibliographicCitationBagheri Nejad S, Allegranzi B, Syed SB, Ellis B, Pittet D. Health-care-associated infection in Africa: a systematic review. Bull World Health Organ. 2011 Oct 1;89(10):757–65
dc.source.bibliographicCitationAl-Tawfiq JA, Tambyah PA. Healthcare associated infections (HAI) perspectives. J Infect Public Health. 2014 Aug;7(4):339–44
dc.source.bibliographicCitation. Sydnor ERM, Perl TM. Hospital Epidemiology and Infection Control in Acute-Care Settings. Clin Microbiol Rev. 2011 Jan;24(1):141–73
dc.source.bibliographicCitationLindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ. 1991 Mar 23;302(6778):709–11
dc.source.bibliographicCitationEaton TE, Grey C, Garrett JE. An evaluation of short-term oxygen therapy: the prescription of oxygen to patients with chronic lung disease hypoxic at discharge from hospital. Respir Med. 2001 Jul;95(7):582–7
dc.source.bibliographicCitationAbernethy AP, McDonald CF, Frith PA, Clark K, Herndon JE, Marcello J, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet Lond Engl. 2010 Sep 4;376(9743):784–93
dc.source.bibliographicCitationBen-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM. Interventions for alleviating cancer-related dyspnea: a systematic review and meta-analysis. Acta Oncol Stockh Swed. 2012 Nov;51(8):996–1008
dc.source.bibliographicCitationHeffner JE. The Story of Oxygen. Respir Care. 2013 Jan 1;58(1):18–31
dc.source.bibliographicCitationDevelopment WHOD of C and AH and, Technologies WHOD of EH. Informal consultation on clinical use of oxygen : meeting report, 2-3 October 2003. 2004 [cited 2018 May 29]; Available from: http://apps.who.int/iris/handle/10665/69706
dc.source.bibliographicCitationSuntharalingam J, Hippolyte S, Knowles V, Freeman D, Patel I, Hardinge M. When should I be considering home oxygen for my patients? NPJ Prim Care Respir Med. 2016 Jan 7;26:15074
dc.source.bibliographicCitationHardinge M, Annandale J, Bourne S, Cooper B, Evans A, Freeman D, et al. British Thoracic Society guidelines for home oxygen use in adults. Thorax. 2015 Jun;70 Suppl 1:i1-43
dc.source.bibliographicCitationRingbaek TJ. Continuous oxygen therapy for hypoxic pulmonary disease: guidelines, compliance and effects. Treat Respir Med. 2005;4(6):397–408
dc.source.bibliographicCitationOkubadejo AA, Paul EA, Jones PW, Wedzicha JA. Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia? Eur Respir J. 1996 Nov;9(11):2335–9
dc.source.bibliographicCitationHeaton RK, Grant I, McSweeny AJ, Adams KM, Petty TL. Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1983 Oct;143(10):1941–7
dc.source.bibliographicCitationGorecka D, Gorzelak K, Sliwinski P, Tobiasz M, Zielinski J. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax. 1997 Aug;52(8):674–9
dc.source.bibliographicCitationGulbas G, Gunen H, In E, Kilic T. Long-term follow-up of chronic obstructive pulmonary disease patients on long-term oxygen treatment. Int J Clin Pract. 2012 Feb;66(2):152–7
dc.source.bibliographicCitationSpier S, Rivlin J, Hughes D, Levison H. The effect of oxygen on sleep, blood gases, and ventilation in cystic fibrosis. Am Rev Respir Dis. 1984 May;129(5):712–8. 24. Smith PE, Edwards RH, Calverley PM. Oxygen treatment of sleep hypoxaemia in Duchenne muscular dystrophy. Thorax. 1989 Dec;44(12):997–1001
dc.source.bibliographicCitationBroström A, Hübbert L, Jakobsson P, Johansson P, Fridlund B, Dahlström U. Effects of long-term nocturnal oxygen treatment in patients with severe heart failure. J Cardiovasc Nurs. 2005;20(6):385–96
dc.source.bibliographicCitationAndreas S, Clemens C, Sandholzer H, Figulla HR, Kreuzer H. Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol. 1996 May;27(6):1486–90
dc.source.bibliographicCitationGonzález-Moro JMR, Navarrete BA, Michavila IA, Lobato SD. Oxigenoterapia continua domiciliaria. Monogr Arch Bronconeumol [Internet]. 2016 Jan 15 [cited 2018 May 29];2(5). Available from:http://separcontenidos.es/revista/index.php/revista/article/view/140
dc.source.bibliographicCitationGallagher JL, McKernan G, Slater L, DeRamon A. P44 How Long is short term Oxygen Therapy? Home Oxygen Prescriptions Post Hospitalisation. Thorax. 2012 Dec 1;67(Suppl 2):A82–A82
dc.source.bibliographicCitationArciniegas W, Bolívar F, Cano DJ. Evaluación de costos de un programa de oxigenoterapia domiciliaria. Rev Salud UIS [Internet]. 2010 [cited 2018 May 29];42(1). Available from: http://revistas.uis.edu.co/index.php/revistasaluduis/article/view/789
dc.source.bibliographicCitationMasa JF, Sobradillo V, Villasante C, Jiménez-Ruiz CA, Fernández-Fau L, Viejo JL, et al. Costs of Chronic Obstructive Pulmonary Disease in Spain: Estimation From a Population-Based Study. Arch Bronconeumol Engl Ed. 2004 Feb 1;40(2):72–9
dc.source.bibliographicCitationCasas F, Carlos J, Schiavi E, Mazzei JA, López AM, Rhodius E, et al. Recomendaciones para la prevención, diagnóstico y tratamiento de LA EPOC en la Argentina. Med B Aires. 2012 Aug;72(4):1–33
dc.source.bibliographicCitationWarner JL, Zhang P, Liu J, Alterovitz G. Classification of hospital acquired complications using temporal clinical information from a large electronic health record. J Biomed Inform. 2016 Feb;59:209–17
dc.source.bibliographicCitationKlevens RM, Edwards JR, Richards CL, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep Wash DC 1974. 2007 Apr;122(2):160–6
dc.source.bibliographicCitationFuller RL, McCullough EC, Bao MZ, Averill RF. Estimating the costs of potentially preventable hospital acquired complications. Health Care Financ Rev. 2009;30(4):17–32. 35. Bohlouli B, Tonelli M, Jackson T, Hemmelgam B, Klarenbach S. Risk of Hospital-Acquired Complications in Patients with Chronic Kidney Disease. Clin J Am Soc Nephrol CJASN. 2016 Jun 6;11(6):956–63
dc.source.bibliographicCitationAllegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet Lond Engl. 2011 Jan 15;377(9761):228–41
dc.source.bibliographicCitationKhan HA, Baig FK, Mehboob R. Nosocomial infections: Epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed. 2017 May 1;7(5):478–82
dc.source.bibliographicCitationHoran TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008 Jun;36(5):309–32
dc.source.bibliographicCitationVincent J-L, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009 Dec 2;302(21):2323–9
dc.source.bibliographicCitationNicolaides AN, Fareed J, Kakkar AK, Comerota AJ, Goldhaber SZ, Hull R, et al. Prevention and treatment of venous thromboembolism--International Consensus Statement. Int Angiol J Int Union Angiol. 2013 Apr;32(2):111–260
dc.source.bibliographicCitationAssareh H, Chen J, Ou L, Hillman K, Flabouris A. Incidences and variations of hospital acquired venous thromboembolism in Australian hospitals: a population-based study. BMC Health Serv Res. 2016 Sep 22;16(1):511
dc.source.bibliographicCitationHeit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015 Aug;12(8):464–74
dc.source.bibliographicCitationKucher N, Koo S, Quiroz R, Cooper JM, Paterno MD, Soukonnikov B, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005 Mar 10;352(10):969–77
dc.source.bibliographicCitationHealthGrades patient safety study shows increase in hospital incidents, gaps among state, hospitals [Internet]. EurekAlert! [cited 2018 May 29]. Available from: http://www.eurekalert.org/pub_releases/2006-04/h-hps032806.php
dc.source.bibliographicCitationDennis RJ, Acevedo JR, Restrepo HF, Hernández JI, Rivas E, Sabogal JE. Is current prophylaxis against venous thromboembolism (VTE) appropriate in medical patients?: Evaluation of Colombian outcomes in the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE). Acta Medica Colomb. 2009 Mar;34(1):11–6
dc.source.bibliographicCitationQadeer MA, Richter JE, Brotman DJ. Hospital-acquired gastrointestinal bleeding outside the critical care unit: risk factors, role of acid suppression, and endoscopy findings. J Hosp Med. 2006 Jan;1(1):13–20.
dc.source.bibliographicCitationKaplan RC, Heckbert SR, Koepsell TD, Furberg CD, Polak JF, Schoen RE, et al. Risk factors for hospitalized gastrointestinal bleeding among older persons. Cardiovascular Health Study Investigators. J Am Geriatr Soc. 2001 Feb;49(2):126–33.
dc.source.bibliographicCitationHerzig SJ, Rothberg MB, Feinbloom DB, Howell MD, Ho KKL, Ngo LH, et al. Risk factors for nosocomial gastrointestinal bleeding and use of acid-suppressive medication in non-critically ill patients. J Gen Intern Med. 2013 May;28(5):683–90
dc.source.bibliographicCitationValle B, Díaz JA, López JJ, Calderón CM. Evaluación de la prescripción profiláctica de omeprazol y ranitidina mediante la identificación de factores de riesgo de sangrado gastrointestinal. Rev Colomb Cienc Quím-Farm. 2017 Jan 1;46(1):36–47
dc.source.bibliographicCitationKillen J, Ellis H. Assisted discharge for patients with exacerbations of chronic obstructive pulmonary disease: safe and effective. Thorax. 2000 Nov 1;55(11):885–885
dc.source.bibliographicCitationInstituto de Cardiologia, Fundacion Cardioinfantil Colombia [Internet]. [cited 2018 May 29]. Available from: http://www.cardioinfantil.org/index.php/conoce-la-fundacion
dc.source.bibliographicCitationGardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J Clin Res Ed. 1986 Mar 15;292(6522):746–50
dc.source.bibliographicCitationSaavedra CH, Ordóñez KM, Díaz JA. Impacto de la infección nosocomial en un hospital de Bogotá (Colombia): efectos en mortalidad y costos. Rev Chil Infectol. 2015 Feb;32(1):25–9
dc.source.bibliographicCitationSaltman AP, Silver FL, Fang J, Stamplecoski M, Kapral MK. Care and Outcomes of Patients With In-Hospital Stroke. JAMA Neurol. 2015 Jul;72(7):749–55
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.


Archivos en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

 

Reconocimientos: